CLOs on the Move

PinnacleCare International

www.pinnaclecare.com

 
PinnacleCare International is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Baltimore, MD. To find more information about PinnacleCare International, please visit www.pinnaclecare.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

bodyevolutionorg

bodyevolutionorg is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Chicago Institute for Psychoanalysis

The Chicago Institute for Psychoanalysis is a national leader in psychoanalytic education, scholarship and clinical services to the community. The Institute educates mental health professionals as adult and child psychoanalysts and psychotherapists in its Psychoanalytic Education Program, Adult Psychotherapy Program and Child and Adolescent Psychotherapy Program. Through its clinics, the Institute provides psychotherapy on a sliding scale to adults and children, serving some of Chicago`s most vulnerable and under served communities. It also offers community education programs and consultation to schools, courts, businesses and other organizations. Institute graduates and faculty are highly skilled practitioners of psychoanalysis and psychotherapy and are the teachers, supervisors and consultants to new generations of mental health practitioners.

YMCA of Central New York

At the Y, our cause is strengthening the foundations of community.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Neuwave

NeuWave Medical specializes in developing and commercializing energy-based minimally invasive medical devices. These devices must deliver improved healthcare economics and a better experience for patients in terms of outcomes or quality of life. NeuWave Medical, Inc. is a spin-off company from the University of Wisconsin - Madison. NeuWave arose as the result of an academic collaboration between engineers and physicians who wished to improve their ability to treat cancer and other important clinical problems. As a result, NeuWave is highly focused on solving real clinical problems in a manner that will directly benefit patients by being more effective, minimally invasive, and cost conscious.